HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoya Tanaka Selected Research

DM 235

10/2013Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoya Tanaka Research Topics

Disease

2Alzheimer Disease (Alzheimer's Disease)
10/2013 - 04/2013
1Back Pain (Backache)
01/2020
1Hyperalgesia
01/2020
1Brain Injuries (Brain Injury)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2013

Drug/Important Bio-Agent (IBA)

1Teriparatide (Parathar)FDA Link
01/2020
1Parathyroid Hormone (Parathormone)IBA
01/2020
1Minocycline (Cyclops)FDA LinkGeneric
01/2019
1Piracetam (Nootropil)IBA
10/2013
1Pyrrolidinones (Pyrrolidones)IBA
10/2013
1Nootropic Agents (Nootropics)IBA
10/2013
1DM 235IBA
10/2013
1Cholinergic Agents (Cholinergics)IBA
04/2013

Therapy/Procedure

1Ovariectomy (Oophorectomy)
01/2020